"AOP Orphan is fully dedicated to develop new treatments for patients with rare diseases. Everyday we do our best to understand and to serve the patients needs!"
Personal Data Sheet
Martin Steinhart holds a medical doctor diploma in human medicine from the University of Vienna, Medical School. He gathered a solid national and international experience in various pharmaceutical companies in the fields of Medical Affairs, Clinical and Regulatory Operations as well as Safety & Quality in Austria and CEE. He joined AOP Orphan in July 2019 as a Chief of Research & Development being accountable for the organizational, structural and strategic set up of the R&D area.